Neuroprotective effects of M826, a reversible caspase-3 inhibitor, in the rat malonate model of Huntington's disease.
Toulmond S, Tang K, Bureau Y, Ashdown H, Degen S, O'Donnell R, Tam J, Han Y, Colucci J, Giroux A, Zhu Y, Boucher M, Pikounis B, Xanthoudakis S, Roy S, Rigby M, Zamboni R, Robertson GS, Ng GY, Nicholson DW, Flückiger JP.
Toulmond S, et al. Among authors: roy s.
Br J Pharmacol. 2004 Feb;141(4):689-97. doi: 10.1038/sj.bjp.0705662. Epub 2004 Jan 26.
Br J Pharmacol. 2004.
PMID: 14744804
Free PMC article.